Physician profile
Richard Pham
NPI 1245282938
$852.90
in general payments reported to CMS, 2019-2025
11 companies · $93.32 in 2025
The $93.32 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $151 · 2021: $171 · 2022: $57.89 · 2023: $95.21 · 2024: $23.00 · 2025: $93.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189 · Travel and Lodging: $23.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.53 |
| Travel and Lodging | $23.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $327.95 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $116.91 | 2019 | |
| Smith+Nephew, INC. | $108.11 | 2022-2023 | Grafix Pl |
| Boston Scientific Corporation | $93.32 | 2025 | Farapulse |
| Amgen INC. | $81.15 | 2019-2020 | |
| Biosense Webster, INC. | $32.53 | 2022 | |
| Astellas Pharma US INC | $23.90 | 2019 | |
| Philips North America LLC | $23.00 | 2024 | (Br0) Coronary Atherectomy |
| Astrazeneca Pharmaceuticals Lp | $18.20 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.14 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.